This proposal represents a collaboration between the University of Pennsylvania, the Children's Hospital of Philadelphia and the Wistar Institute to establish a Center for AIDS research that would link the AIDS research communities at these three institutions within an administrative structure committed to fostering interdisciplinary AIDS research activities. The Penn-CFAR would be established as a distinct University Center whose members would be derived from multiple Schools, Departments and Institutes located on the Penn campus and whose Director would report directly to the Dean of the University of Penn. School of Medicine. The primary goals of the Penn-CFAR will be 1) to create an infrastructure that facilitates communication, collaboration and synergy among AIDS/HIV researchers; 2) to establish shared resource cores facilities that enhance the overall research environment for individual investigators and that promote interdisciplinary research activities; 3) to develop programs in community outreach and AIDS education for students and faculty, and 4) to stimulate the recruitment of new faculty that will help to develop clinical and basic science programs that are at the forefront of AIDS research. The Penn- CFAR will be organized around 5 research programs: HIV Pathogenesis, Structural Biology, Clinical/Therapeutics, Immunology/Vaccine and Behavioral and Social Sciences. The Center will be directed by Dr. James A. Hoxie with the assistance of a Co-Director (Dr. Francisco Gonzalez- Scarano) and an Executive Committee whose membership includes senior scientists from the 5 Penn-CFAR Programs (Drs. Linda Aiken, Irwin Chaiken, Robert Doms, Harvey Friedman, Michael Malim, Stuart Starr, Peter Traber and James Wilson). In year 1 this CFAR will support an Administrative Core, a Developmental core, and 7 shared resource cores including Clinical/Therapeutics, Virus/Primary Cell, Molecular, Structural Biology, Immunology, Behavioral and Social Sciences, and Biostatistics and Data Management. The Center will be committed to developing a creative, comprehensive, and interdisciplinary AIDS research program that is fully integrated into the research and educational mission of the University and that will become the focal point for a continuing commitment at Penn, CHOP and Wister to meet the challenges posed by the AIDS pandemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-03
Application #
6374106
Study Section
Special Emphasis Panel (ZAI1-EWS-A (J1))
Program Officer
Young, Janet M
Project Start
1999-07-01
Project End
2004-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
3
Fiscal Year
2001
Total Cost
$1,353,748
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Clarke, Erik L; Lauder, Abigail P; Hofstaedter, Casey E et al. (2018) Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low-Microbial Content Samples. Am J Respir Crit Care Med 197:225-234
Barbian, Hannah J; Connell, Andrew Jesse; Avitto, Alexa N et al. (2018) CHIIMP: An automated high-throughput microsatellite genotyping platform reveals greater allelic diversity in wild chimpanzees. Ecol Evol 8:7946-7963
Meyers, Kathrine; Rodriguez, Kristina; Brill, Atrina L et al. (2018) Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. AIDS Behav 22:1209-1216
Abdel-Mohsen, Mohamed; Kuri-Cervantes, Leticia; Grau-Exposito, Judith et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10:
Barbian, Hannah J; Li, Yingying; Ramirez, Miguel et al. (2018) Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees. Am J Primatol 80:
Ke, Ruian; Li, Hui; Wang, Shuyi et al. (2018) Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. Proc Natl Acad Sci U S A 115:E7139-E7148
Park, Yoon-Dong; Jarvis, Joseph N; Hu, Guowu et al. (2018) Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. MBio 9:
MacBrayne, Christine E; Marks, Kristen M; Fierer, Daniel S et al. (2018) Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate. J Antimicrob Chemother 73:2112-2119
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:

Showing the most recent 10 out of 775 publications